Rocket Doctor AI

Rocket Doctor AI Receivables

Delisted

Accounts Receivable of Rocket Doctor AI (TRUE.CN) as of Nov 16, 2026.

Receivables

0.00CAD

Last updated:

Accounts Receivable of Rocket Doctor AI is 2024 0.00 CAD. Accounts Receivable of Rocket Doctor AI was 2023 17,300.00 CAD. It decreases by % lower compared to the previous year.

The Rocket Doctor AI Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2021
700.00 CAD
Jan 1, 2022
700.00 CAD
Jan 1, 2023
17,300.00 CAD
Jan 1, 2024
0.00 CAD
The Rocket Doctor AI Receivables history
YEARReceivablesYoY
0.00CAD-100.00%
17,300.00CAD+2,371.43%
700.00CAD0.00%
700.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rocket Doctor AI Stock analysis

What does Rocket Doctor AI do? Treatment.com AI Inc generates revenue through its Treatment Digital Health App, a symptom assessment tool developed by a global team of doctors and engineers. The app provides predictive health insights using disease rate estimates, geographic variation data, and medical research, targeting patients and caregivers seeking informed health decisions. The company also offers medical education solutions and clinical advisor services, serving healthcare professionals and institutions globally. Revenue streams include subscriptions for app access and tailored medical education programs. The Treatment Digital Health App is designed for widespread use, offering advanced medical knowledge access to users worldwide. Medical clinic solutions are integrated into the platform, supporting healthcare providers in decision-making. Clinical advisor services leverage the AI platform to assist clinics and institutions with specialized medical guidance. These offerings are marketed to healthcare consumers, clinics, and educational institutions as part of the company's global healthcare technology strategy. Treatment.com AI Inc's business model focuses on AI-driven health solutions, with the Treatment Digital Health App as its primary product. The app's predictive health assessments are updated regularly by medical professionals, ensuring relevance and accuracy. The company monetizes through direct consumer subscriptions and B2B partnerships with medical clinics and educational providers, emphasizing global accessibility and evidence-based medical insights. Rocket Doctor AI is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rocket Doctor AI stock

On Eulerpool you can find the complete historical development of Accounts Receivable Rocket Doctor AI since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Rocket Doctor AI historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Rocket Doctor AI

All Key Metrics — Rocket Doctor AI